Burning Rock Biotech Limited IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Burning Rock Biotech Limited | BNR - NASDAQ |
$13.50-$15.50 | $16.50 | $22.80 | 13.5 million ADSs | 6/12/2020 |
| Morgan Stanley, BofA Securities, Cowen | ||||||
Co-Manager(s): CMBI, Tiger Brokers | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-05-22 Terms Added 2020-06-05 | ||||||
Burning Rock Biotech Limited Quote & Chart - Click for current quote - BNR
IPO Boutique aggregates information on public companies and private companies, such as "BNR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Burning Rock Biotech Limited (adapted from Burning Rock Biotech Limited prospectus):
They are a Chinese biotech company that aims to transform precision oncology and early cancer detection.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a Chinese biotech company that aims to transform precision oncology and early cancer detection.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "BNR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.